Socionext (6526) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
30 Jan, 2026Executive summary
Net sales for 3Q FY2026/3 rose 19.2% year-over-year to ¥54.9B, with product revenue up 26.4% and NRE revenue up 30.9% sequentially, driven by new automotive mass production and strong demand in key markets.
For the first nine months ended December 31, 2025, net sales were ¥142.1B, down 2.2% year-over-year, with operating income at ¥7.2B (down 65.1%) and net income at ¥4.8B (down 71%).
Product revenue bottomed out in Q1 and rebounded, driven by new automotive products for China, but overall product revenue declined 0.3% and NRE revenue fell 9.2% year-over-year.
Operating income for 3Q FY2026/3 increased 47.7% sequentially to ¥3.4B, but declined 32.7% year-over-year due to a higher product cost ratio and increased R&D expenses.
The company continued to invest in advanced semiconductor technologies and expanded its chiplet development platform.
Financial highlights
Gross profit for the period was ¥65.8B, with a gross margin decline due to lower-margin new products and increased development investment.
Ordinary income was ¥6.6B, down 68.6% year-over-year, impacted by foreign exchange losses and higher costs.
Cash on hand and in banks decreased to ¥43.8B as of December 31, 2025, from ¥72.8B at the previous fiscal year-end.
Inventories rose to ¥32.8B, reflecting higher regular inventory and customer-reserved stock.
Net cash provided by operating activities was ¥2.8B, down sharply from ¥23.5B in the prior year period.
Outlook and guidance
Full-year FY2026/3 net sales forecast is ¥190.0B (+0.8% vs. prior year), with operating income forecast at ¥10.0B (-60.0%) and net income at ¥6.7B (-65.8%).
Basic EPS forecasted at ¥38.16 and dividend at ¥50 per share.
Product cost ratio is expected to remain elevated in FY26/3 due to new product mix and FX impact, but improvement is anticipated from FY27/3 onward.
Operating margin is expected to recover in FY27/3 and beyond as product revenue grows and cost structure improves.
Latest events from Socionext
- Sales guidance raised but profit outlook cut as margins shrink amid higher costs and weak demand.6526
Q2 202631 Oct 2025 - Sharp profit and sales drop in 1Q FY26/3, but full-year guidance and recovery outlook are maintained.6526
Q1 202631 Jul 2025 - Sales and profit fell, but R&D and NRE revenue rose; treasury stock buyback approved.6526
Q2 202513 Jun 2025 - Net sales fell 14.1% but operating income and R&D investment both increased.6526
Q1 202513 Jun 2025 - Revenue and profit fell sharply, but investments and design wins support future growth.6526
Q4 20256 Jun 2025 - Net sales dropped 14.4% and the full-year outlook was cut amid weak China demand.6526
Q3 20255 Jun 2025